Bio-Techne (TECH) Free Cash Flow (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.42% |
| Dec 31, 2025 | 244.21% |
| Sep 30, 2025 | -76.19% |
| Jun 30, 2025 | 201.03% |
| Mar 31, 2025 | -60.02% |
| Dec 31, 2024 | 41.68% |
| Sep 30, 2024 | -4.87% |
| Jun 30, 2024 | -10.89% |
| Mar 31, 2024 | -5.43% |
| Dec 31, 2023 | 49.05% |
| Sep 30, 2023 | -36.89% |
| Jun 30, 2023 | 87.08% |
| Mar 31, 2023 | -33.44% |
| Dec 31, 2022 | 25.26% |
| Sep 30, 2022 | -47.81% |
| Jun 30, 2022 | 53.63% |
| Mar 31, 2022 | -36.11% |
| Dec 31, 2021 | 114.39% |
| Sep 30, 2021 | -61.73% |
| Jun 30, 2021 | 72.26% |
| Mar 31, 2021 | -17.42% |
| Dec 31, 2020 | 41.32% |
| Sep 30, 2020 | 100.86% |
| Jun 30, 2020 | -31.77% |
| Mar 31, 2020 | -28.05% |
| Dec 31, 2019 | 86.09% |
| Sep 30, 2019 | -32.18% |
| Jun 30, 2019 | 27.40% |
| Mar 31, 2019 | -17.21% |
| Dec 31, 2018 | 19.01% |
| Sep 30, 2018 | -40.26% |
| Jun 30, 2018 | 225.33% |
| Mar 31, 2018 | -44.77% |
| Dec 31, 2017 | -16.68% |
| Sep 30, 2017 | -12.35% |
| Jun 30, 2017 | 114.15% |
| Mar 31, 2017 | -45.83% |
| Dec 31, 2016 | 61.17% |
| Sep 30, 2016 | -28.38% |
| Jun 30, 2016 | -2.06% |
| Mar 31, 2016 | 1.93% |
| Dec 31, 2015 | 30.88% |
| Sep 30, 2015 | -14.88% |
| Jun 30, 2015 | 16.84% |
| Mar 31, 2015 | -20.66% |
| Dec 31, 2014 | 5.75% |
| Sep 30, 2014 | -13.98% |
| Jun 30, 2014 | 16.78% |
| Mar 31, 2014 | 10.83% |
| Dec 31, 2013 | -3.82% |
| Sep 30, 2013 | 16.77% |
| Jun 30, 2013 | -7.55% |
| Mar 31, 2013 | 15.54% |
| Dec 31, 2012 | -13.76% |
| Sep 30, 2012 | -26.27% |
| Jun 30, 2012 | 10.35% |
| Mar 31, 2012 | 80.27% |
| Dec 31, 2011 | -45.29% |
| Sep 30, 2011 | -0.19% |
| Jun 30, 2011 | 5.05% |
| Mar 31, 2011 | 10.70% |
| Dec 31, 2010 | -3.14% |
| Sep 30, 2010 | -3.28% |
| Jun 30, 2010 | 40.29% |
| Mar 31, 2010 | -17.98% |
| Dec 31, 2009 | -3.00% |